The CONSORT extension for reporting trials where health equity is relevant was published in 2017 in-line with the CONSORT 2010 checklist items. Relevant documents are linked to and can be downloaded below.
The CONSORT-Equity 2017 Extension aims to improve the reporting of intervention effects in randomised trials where health equity is relevant. We define a trial where health equity is relevant as one that assesses effects on health equity by evaluating an intervention focused on people experiencing social disadvantage or by exploring the difference in the effect of the intervention between two groups (or as a gradient across more than two groups) experiencing different levels of social disadvantage, or both. Health inequities are unfair differences in health that can be avoided by reasonable action.
|Document||Word Format||PDF Format|
Welch VA, Norheim OF, Jull J, Cookson R, Sommerfelt H, Tugwell P, et al. CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials. BMJ (Clinical research ed). British Medical Journal Publishing Group; 2017 Nov 23;359:j5085. PMID: 29170161